2VL9
Oxidized form of human peroxiredoxin 5
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ESRF BEAMLINE BM30A |
Synchrotron site | ESRF |
Beamline | BM30A |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2005-11-11 |
Detector | MARRESEARCH |
Spacegroup name | P 31 2 1 |
Unit cell lengths | 75.870, 75.870, 193.254 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | 46.000 - 2.700 |
R-factor | 0.1863 |
Rwork | 0.184 |
R-free | 0.23900 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 1oc3 |
RMSD bond length | 0.006 |
RMSD bond angle | 1.636 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Phasing software | PHASER |
Refinement software | PHENIX ((PHENIX.REFINE)) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 46.000 | 2.750 |
High resolution limit [Å] | 2.700 | 2.700 |
Rmerge | 0.050 | 0.460 |
Number of reflections | 18076 | |
<I/σ(I)> | 17.9 | 3.4 |
Completeness [%] | 98.1 | 99.6 |
Redundancy | 4.05 | 4.05 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | 6.5 | PEG 8000 20% SODIUM CACODYLATE 0.1 M PH 6.5 SODIUM ACETATE 0.1 M 6-AMINOCAPROIC ACID 3% W/V |